AXL and cancer: In the GSE14333 cohort, AXL mRNA expression (HR = 1.631, 95% CI = 1.076–2.471, p = 0.021; Figure 3C) was an independent predictor of patient survival with tumor staging (p<0.001), while in the GSE17538 cohort, AXL mRNA expression (HR = 3.700, 95% CI = 1.665–8.220, p = 0.001; Figure 3D) was an independent predictor of patient survival together with stage (p<0.001) and grade (p = 0.055) of the cancers.